Risk assessment criteria in liver transplantation for hepatocellular carcinoma: proposal to improve transplant oncology.
Hepat Oncol
; 7(3): HEP26, 2020 Jul 24.
Article
em En
| MEDLINE
| ID: mdl-32774836
ABSTRACT
Liver transplantation for hepatocellular carcinoma has proved to be a highly effective cure if the right patient can be selected. Milan criteria has traditionally guided physicians toward appropriate liver allocation but changes in clinical practice, patient populations and recent developments in biomarkers are decreasing Milan criteria's utility. At the same time, the literature has flooded with a diversity of new criteria that demonstrate strong predictive power and are better suited for current clinical practice. In this article, the utility of newly proposed criteria will be reviewed and important issues to improve future criteria will be addressed in hopes of opening a discussion on how key questions surrounding criteria for liver transplantation of hepatocellular carcinoma can be answered.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Etiology_studies
/
Prognostic_studies
/
Qualitative_research
/
Risk_factors_studies
Idioma:
En
Revista:
Hepat Oncol
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
Estados Unidos